229 related articles for article (PubMed ID: 25656427)
21. Atorvastatin inhibits hypercholesterolemia-induced calcification in the aortic valves via the Lrp5 receptor pathway.
Rajamannan NM; Subramaniam M; Caira F; Stock SR; Spelsberg TC
Circulation; 2005 Aug; 112(9 Suppl):I229-34. PubMed ID: 16159822
[TBL] [Abstract][Full Text] [Related]
22. Expression of low-density lipoprotein-related receptors 5 and 6 (LRP5/6) in psoriasis skin.
Duvetorp A; Olsen RS; Nyström H; Skarstedt M; Dienus O; Mrowietz U; Söderman J; Seifert O
Exp Dermatol; 2017 Nov; 26(11):1033-1038. PubMed ID: 28418602
[TBL] [Abstract][Full Text] [Related]
23. LRP5 promotes cancer stem cell traits and chemoresistance in colorectal cancer.
Nie X; Liu H; Ye W; Wei X; Fan L; Ma H; Li L; Xue W; Qi W; Wang YD; Chen WD
J Cell Mol Med; 2022 Feb; 26(4):1095-1112. PubMed ID: 34997691
[TBL] [Abstract][Full Text] [Related]
24. Lrp5 and Lrp6 play compensatory roles in mouse intestinal development.
Zhong Z; Baker JJ; Zylstra-Diegel CR; Williams BO
J Cell Biochem; 2012 Jan; 113(1):31-8. PubMed ID: 21866564
[TBL] [Abstract][Full Text] [Related]
25. Curcumin modulation of high fat diet-induced atherosclerosis and steatohepatosis in LDL receptor deficient mice.
Hasan ST; Zingg JM; Kwan P; Noble T; Smith D; Meydani M
Atherosclerosis; 2014 Jan; 232(1):40-51. PubMed ID: 24401215
[TBL] [Abstract][Full Text] [Related]
26. BMP-2 controls alkaline phosphatase expression and osteoblast mineralization by a Wnt autocrine loop.
Rawadi G; Vayssière B; Dunn F; Baron R; Roman-Roman S
J Bone Miner Res; 2003 Oct; 18(10):1842-53. PubMed ID: 14584895
[TBL] [Abstract][Full Text] [Related]
27. Hepatocyte growth factor (Hgf) stimulates low density lipoprotein receptor-related protein (Lrp) 5/6 phosphorylation and promotes canonical Wnt signaling.
Koraishy FM; Silva C; Mason S; Wu D; Cantley LG
J Biol Chem; 2014 May; 289(20):14341-50. PubMed ID: 24692544
[TBL] [Abstract][Full Text] [Related]
28. Vascular smooth muscle LRP6 limits arteriosclerotic calcification in diabetic LDLR-/- mice by restraining noncanonical Wnt signals.
Cheng SL; Ramachandran B; Behrmann A; Shao JS; Mead M; Smith C; Krchma K; Bello Arredondo Y; Kovacs A; Kapoor K; Brill LM; Perera R; Williams BO; Towler DA
Circ Res; 2015 Jul; 117(2):142-56. PubMed ID: 26034040
[TBL] [Abstract][Full Text] [Related]
29. LRPs in WNT Signalling.
Davidson G
Handb Exp Pharmacol; 2021; 269():45-73. PubMed ID: 34490514
[TBL] [Abstract][Full Text] [Related]
30. [Effect of the Wnt/LRP5/β-catenin signaling pathway on the pathogenesis of postmenopausal osteoporosis].
Wang Y; Liu Y; Ma JX; Li BX; Li YK
Zhonghua Fu Chan Ke Za Zhi; 2011 Oct; 46(10):769-72. PubMed ID: 22321352
[TBL] [Abstract][Full Text] [Related]
31. Lack of Lrp5 Signaling in Osteoblasts Sensitizes Male Mice to Diet-Induced Disturbances in Glucose Metabolism.
Kim SP; Frey JL; Li Z; Goh BC; Riddle RC
Endocrinology; 2017 Nov; 158(11):3805-3816. PubMed ID: 28938444
[TBL] [Abstract][Full Text] [Related]
32. Mesenchymal Wnt signaling promotes formation of sternum and thoracic body wall.
Snowball J; Ambalavanan M; Cornett B; Lang R; Whitsett J; Sinner D
Dev Biol; 2015 May; 401(2):264-75. PubMed ID: 25727890
[TBL] [Abstract][Full Text] [Related]
33. LRP5: A novel anti-inflammatory macrophage marker that positively regulates migration and phagocytosis.
Ma Y
J Mol Cell Cardiol; 2016 Feb; 91():61-2. PubMed ID: 26739212
[No Abstract] [Full Text] [Related]
34. Multiple modes of Lrp4 function in modulation of Wnt/β-catenin signaling during tooth development.
Ahn Y; Sims C; Murray MJ; Kuhlmann PK; Fuentes-Antrás J; Weatherbee SD; Krumlauf R
Development; 2017 Aug; 144(15):2824-2836. PubMed ID: 28694256
[TBL] [Abstract][Full Text] [Related]
35. Distinct roles of LRP5 and LRP6 in Wnt signaling regulation in the retina.
Singh HD; Ma JX; Takahashi Y
Biochem Biophys Res Commun; 2021 Mar; 545():8-13. PubMed ID: 33545636
[TBL] [Abstract][Full Text] [Related]
36. LRP5 Promotes Gastric Cancer via Activating Canonical Wnt/β-Catenin and Glycolysis Pathways.
Nie X; Wang H; Wei X; Li L; Xue T; Fan L; Ma H; Xia Y; Wang YD; Chen WD
Am J Pathol; 2022 Mar; 192(3):503-517. PubMed ID: 34896072
[TBL] [Abstract][Full Text] [Related]
37. Peptide-based mediated disruption of N-cadherin-LRP5/6 interaction promotes Wnt signaling and bone formation.
Haÿ E; Buczkowski T; Marty C; Da Nascimento S; Sonnet P; Marie PJ
J Bone Miner Res; 2012 Sep; 27(9):1852-63. PubMed ID: 22576936
[TBL] [Abstract][Full Text] [Related]
38. Severe hypercholesterolemia, impaired fat tolerance, and advanced atherosclerosis in mice lacking both low density lipoprotein receptor-related protein 5 and apolipoprotein E.
Magoori K; Kang MJ; Ito MR; Kakuuchi H; Ioka RX; Kamataki A; Kim DH; Asaba H; Iwasaki S; Takei YA; Sasaki M; Usui S; Okazaki M; Takahashi S; Ono M; Nose M; Sakai J; Fujino T; Yamamoto TT
J Biol Chem; 2003 Mar; 278(13):11331-6. PubMed ID: 12509421
[TBL] [Abstract][Full Text] [Related]
39. Huogu I formula prevents steroid-induced osteonecrosis in rats by down-regulating PPARgamma expression and activating wnt/LRP5/ beta-catenin signaling.
Jiang Y; Liu D; Kong X; Xu Y; Chen W; Lin N
J Tradit Chin Med; 2014 Jun; 34(3):342-50. PubMed ID: 24992763
[TBL] [Abstract][Full Text] [Related]
40. Genetic Deletion of LRP5 and LRP6 in Macrophages Exacerbates Colitis-Associated Systemic Inflammation and Kidney Injury in Response to Intestinal Commensal Microbiota.
Manoharan I; Swafford D; Shanmugam A; Patel N; Prasad PD; Mohamed R; Wei Q; Dong Z; Thangaraju M; Manicassamy S
J Immunol; 2022 Jul; 209(2):368-378. PubMed ID: 35760519
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]